NCT00239252已完成3 期
Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 5
研究概览
简要总结
Efficacy and safety is compared between interferon alfacon-1 alone and concomitant dosing of interferon alfacon-1 and ribavirin in hepatitis C patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hepatitis C patients (high titer, genotype1)
排除标准
- •Patients with autoimmune disorder
- •Patients with negative HBs antigen
- •Patients with hepatic cirrhosis, hepatic failure and hepatic cancer
- •Patients with depression or psychoneurotic disorder
研究者
研究点 (5)
Loading locations...
相似试验
已完成
2 期
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)Chronic Hepatitis CNCT00084279InterMune81
已完成
3 期
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease UveitisBehçet DiseaseUveitisNCT03209219Peking Union Medical College Hospital28
已完成
3 期
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus InfectionChronic Hepatitis B Virus InfectionNCT06544551Beijing Kawin Technology Share-Holding Co., Ltd.336
撤回
不适用
Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive PatientsChronic Hepatitis CNCT00571714University of Nebraska
已完成
1 期
Comparison Study of PF530 and Betaferon in Healthy SubjectsMultiple SclerosisNCT02474134Pfenex, Inc12